Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2026-01-01 @ 6:56 PM
Study NCT ID:
NCT07103668
Status:
RECRUITING
Last Update Posted:
2025-10-23
First Post:
2025-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Sponsor:
Suzhou Immunofoco Biotechnology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-17
First Submit QC Date:
None
Study First Post Date:
2025-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-21
Last Update Post Date:
2025-10-23
Last Update Post Date Type:
ESTIMATED